OCCLQ3 FY24

OCCL Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 130P/E: 5.8Market Cap: ₹131 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

No

Order

N/A

Capex

No

0 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • Insoluble sulphur division expected to grow around 5% annually with volume growth of 6% to 7%.
  • Aim to increase global market share in insoluble sulphur from 10% to 12%.
  • Sulfuric acid division expected to operate at full capacity; however, it is a low-margin product compared to insoluble sulphur.
  • Volumes of insoluble sulphur have remained roughly flat over recent years with no significant decline.
  • Volume growth expected to improve from Q4 FY24 onwards after some recent degrowth in Q3.
  • New customer onboarding and market expansion efforts ongoing, especially in North America, but allocations are still limited.
  • Long-term industry outlook remains promising due to anticipated growth in the automotive sector and increasing demand for premium-grade raw materials.
  • Prices and margins expected to remain stable in the near term with challenging market conditions due to oversupply.

See what OCCL management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • There is no explicit mention of any current or future plans for fundraising through debt or equity in the transcript.
  • The company currently has long-term debt of approximately INR 73 crores, with a normal repayment plan of roughly INR 20 crores per year.
  • Post-demerger, the insoluble sulphur business aims to be self-sustaining and self-generating, implying no need for external cash flows.
  • The management clarified there will be no diversion of funds between the insoluble sulphur division and the new investment company post-demerger.
  • Future capital allocation decisions, including potential dividends or debt repayment, will be based on cash flow positions after the demerger.
  • The investment company might undertake new private investments funded from realizations of existing investments rather than fresh fundraising.

See what OCCL management said on order book — free account, 30 seconds.

Capex plans

No
  • Currently, no major reinvestment opportunities are planned in the insoluble sulphur division outside of its core operations.
  • The new capacity addition of 5,500 tons of insoluble sulphur in 2022 is operational with current utilization around 75%.
  • No capex is planned beyond this; focus is on utilizing existing capacity.
  • The investment entity post-demerger will continue to undertake new investments, including private investments or incubating new companies, aimed at maximizing shareholder returns.
  • The demerger is intended to unlock value and separate the investment and manufacturing businesses.
  • Capital allocation decisions, including any dividend or debt repayment plans, will depend on cash flows post-demerger.
  • No specific timeline on new strategic investments; all calls will be prudent and based on cash flow and business needs.

Track OCCL — get its next earnings analysis in your feed

Margin guidance

Category 3
  • The company expects long-term growth in the insoluble sulphur division driven by growth in the automotive sector and tire market, targeting a 5-7% volume growth and increasing global market share from 10% to 12%.
  • Sulfuric acid business is expected to operate at full capacity but yields lower margins compared to insoluble sulphur.
  • Short to medium-term challenges include industry oversupply and price pressures, but pricing and volumes are expected to have bottomed out with gradual recovery in Q4 FY24 compared to Q3 FY24.
  • EBITDA margins declined in recent quarters but the company remains confident in sustained earnings growth over the long term due to strong market positioning and cost-saving initiatives like captive solar power.
  • Post-demerger, focus will be on unlocking shareholder value; reinvestment opportunities are currently limited, with prudent capital allocation aimed at debt repayment, possible dividends or buybacks.
  • Overall, growth in revenue and profits is expected to align with global automotive demand recovery and tightening supply dynamics.

Order book

  • The company has onboarded some new customers from their targeted list for the year; new product approvals are in place.
  • They have started dispatching from January onwards to new North American plants, though allocations are still limited compared to expectations.
  • The orderbook shows a start but is smaller than initially hoped.
  • Future business growth depends on increasing customer confidence and allocations rather than product approval.
  • Volume growth is expected to improve in Q4 FY24 compared to Q3 FY24, indicating potentially better order inflow.
  • The sales model is primarily direct supply to customers' plants.
  • Overall, the company anticipates continued efforts to grow market share and onboarding new clients as allocations improve.

How does OCCL rank vs peers in Chemicals & Petrochemicals?

Pro feature
1OCCL
Rev 4Mar 3

See full Chemicals & Petrochemicals sector rankings

How does OCCL rank in Chemicals & Petrochemicals?

Compare OCCL against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Indo Borax & Chemicals Ltd (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

  • Deepak Fertilisers & Petrochemicals Corp Ltd (Q1 FY27)

    Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…

  • SUDARSCHEM (Q1 FY27)

    Volume growth has been modest (~6% in Q1), with confidence rooted in business recovery and value capture initiatives (Page 6). Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →